154 related articles for article (PubMed ID: 32197075)
1. Bi-allelic LoF NRROS Variants Impairing Active TGF-β1 Delivery Cause a Severe Infantile-Onset Neurodegenerative Condition with Intracranial Calcification.
Dong X; Tan NB; Howell KB; Barresi S; Freeman JL; Vecchio D; Piccione M; Radio FC; Calame D; Zong S; Eggers S; Scheffer IE; Tan TY; Van Bergen NJ; Tartaglia M; Christodoulou J; White SM
Am J Hum Genet; 2020 Apr; 106(4):559-569. PubMed ID: 32197075
[TBL] [Abstract][Full Text] [Related]
2. Novel biallelic variants in NRROS associated with a lethal microgliopathy, brain calcifications, and neurodegeneration.
Macintosh J; Derksen A; Poulin C; Braverman N; Vanderver A; Thiffault I; Albrecht S; Bernard G
Neurogenetics; 2022 Apr; 23(2):151-156. PubMed ID: 35099671
[TBL] [Abstract][Full Text] [Related]
3. Delineating the epilepsy phenotype of NRROS-related microgliopathy: A case report and literature review.
Madaan P; Kaushal Y; Srivastava P; Crow YJ; Livingston JH; Ahuja C; Sankhyan N
Seizure; 2022 Aug; 100():15-20. PubMed ID: 35716448
[TBL] [Abstract][Full Text] [Related]
4. LRRC33 is a novel binding and potential regulating protein of TGF-β1 function in human acute myeloid leukemia cells.
Ma W; Qin Y; Chapuy B; Lu C
PLoS One; 2019; 14(10):e0213482. PubMed ID: 31600200
[TBL] [Abstract][Full Text] [Related]
5. Human TGF-β1 deficiency causes severe inflammatory bowel disease and encephalopathy.
Kotlarz D; Marquardt B; Barøy T; Lee WS; Konnikova L; Hollizeck S; Magg T; Lehle AS; Walz C; Borggraefe I; Hauck F; Bufler P; Conca R; Wall SM; Schumacher EM; Misceo D; Frengen E; Bentsen BS; Uhlig HH; Hopfner KP; Muise AM; Snapper SB; Strømme P; Klein C
Nat Genet; 2018 Mar; 50(3):344-348. PubMed ID: 29483653
[TBL] [Abstract][Full Text] [Related]
6. Latency-associated peptide of transforming growth factor-β1 is not subject to physiological mannose phosphorylation.
Barnes J; Warejcka D; Simpliciano J; Twining S; Steet R
J Biol Chem; 2012 Mar; 287(10):7526-34. PubMed ID: 22262853
[TBL] [Abstract][Full Text] [Related]
7. Biallelic mutations in NRROS cause an early onset lethal microgliopathy.
Smith C; McColl BW; Patir A; Barrington J; Armishaw J; Clarke A; Eaton J; Hobbs V; Mansour S; Nolan M; Rice GI; Rodero MP; Seabra L; Uggenti C; Livingston JH; Bridges LR; Jeffrey IJM; Crow YJ
Acta Neuropathol; 2020 May; 139(5):947-951. PubMed ID: 32100099
[No Abstract] [Full Text] [Related]
8. Role of TGF-β1 Signaling in Heart Valve Calcification Induced by Abnormal Mechanical Stimulation in a Tissue Engineering Model.
Hu XJ; Wu WC; Dong NG; Shi JW; Liu JW; Chen S; Deng C; Shi F
Curr Med Sci; 2018 Oct; 38(5):765-775. PubMed ID: 30341511
[TBL] [Abstract][Full Text] [Related]
9. Bi-allelic JAM2 Variants Lead to Early-Onset Recessive Primary Familial Brain Calcification.
Schottlaender LV; Abeti R; Jaunmuktane Z; Macmillan C; Chelban V; O'Callaghan B; McKinley J; Maroofian R; Efthymiou S; Athanasiou-Fragkouli A; Forbes R; Soutar MPM; Livingston JH; Kalmar B; Swayne O; Hotton G; ; Pittman A; Mendes de Oliveira JR; de Grandis M; Richard-Loendt A; Launchbury F; Althonayan J; McDonnell G; Carr A; Khan S; Beetz C; Bisgin A; Tug Bozdogan S; Begtrup A; Torti E; Greensmith L; Giunti P; Morrison PJ; Brandner S; Aurrand-Lions M; Houlden H
Am J Hum Genet; 2020 Mar; 106(3):412-421. PubMed ID: 32142645
[TBL] [Abstract][Full Text] [Related]
10. NRROS negatively regulates reactive oxygen species during host defence and autoimmunity.
Noubade R; Wong K; Ota N; Rutz S; Eidenschenk C; Valdez PA; Ding J; Peng I; Sebrell A; Caplazi P; DeVoss J; Soriano RH; Sai T; Lu R; Modrusan Z; Hackney J; Ouyang W
Nature; 2014 May; 509(7499):235-9. PubMed ID: 24739962
[TBL] [Abstract][Full Text] [Related]
11. Isoform-specific activation of latent transforming growth factor beta (LTGF-beta) by reactive oxygen species.
Jobling MF; Mott JD; Finnegan MT; Jurukovski V; Erickson AC; Walian PJ; Taylor SE; Ledbetter S; Lawrence CM; Rifkin DB; Barcellos-Hoff MH
Radiat Res; 2006 Dec; 166(6):839-48. PubMed ID: 17149983
[TBL] [Abstract][Full Text] [Related]
12. Activation of latent transforming growth factor-β1, a conserved function for pregnancy-specific beta 1-glycoproteins.
Warren J; Im M; Ballesteros A; Ha C; Moore T; Lambert F; Lucas S; Hinz B; Dveksler G
Mol Hum Reprod; 2018 Dec; 24(12):602-612. PubMed ID: 30371828
[TBL] [Abstract][Full Text] [Related]
13. Latent transforming growth factor-beta complex in Chinese hamster ovary cells contains the multifunctional cysteine-rich fibroblast growth factor receptor, also termed E-selectin-ligand or MG-160.
Olofsson A; Hellman U; Ten Dijke P; Grimsby S; Ichijo H; Morén A; Miyazono K; Heldin CH
Biochem J; 1997 Jun; 324 ( Pt 2)(Pt 2):427-34. PubMed ID: 9182700
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-β1 acts via TβR-I on microglia to protect against MPP(+)-induced dopaminergic neuronal loss.
Liu Z; Chen HQ; Huang Y; Qiu YH; Peng YP
Brain Behav Immun; 2016 Jan; 51():131-143. PubMed ID: 26254549
[TBL] [Abstract][Full Text] [Related]
15. Role of transforming growth factor-beta1 and its latent form binding protein in pseudoexfoliation syndrome.
Schlötzer-Schrehardt U; Zenkel M; Küchle M; Sakai LY; Naumann GO
Exp Eye Res; 2001 Dec; 73(6):765-80. PubMed ID: 11846508
[TBL] [Abstract][Full Text] [Related]
16. Regulation of transforming growth factor beta1 by nitric oxide.
Vodovotz Y; Chesler L; Chong H; Kim SJ; Simpson JT; DeGraff W; Cox GW; Roberts AB; Wink DA; Barcellos-Hoff MH
Cancer Res; 1999 May; 59(9):2142-9. PubMed ID: 10232601
[TBL] [Abstract][Full Text] [Related]
17. Elevated transforming growth factor β signaling activation in β-actin-knockout mouse embryonic fibroblasts enhances myofibroblast features.
Xie X; Percipalle P
J Cell Physiol; 2018 Nov; 233(11):8884-8895. PubMed ID: 29851084
[TBL] [Abstract][Full Text] [Related]
18. Mice deficient in NRROS show abnormal microglial development and neurological disorders.
Wong K; Noubade R; Manzanillo P; Ota N; Foreman O; Hackney JA; Friedman BA; Pappu R; Scearce-Levie K; Ouyang W
Nat Immunol; 2017 Jun; 18(6):633-641. PubMed ID: 28459434
[TBL] [Abstract][Full Text] [Related]
19. The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3).
Maeda S; Dean DD; Gomez R; Schwartz Z; Boyan BD
Calcif Tissue Int; 2002 Jan; 70(1):54-65. PubMed ID: 11907708
[TBL] [Abstract][Full Text] [Related]
20. The single-molecule mechanics of the latent TGF-β1 complex.
Buscemi L; Ramonet D; Klingberg F; Formey A; Smith-Clerc J; Meister JJ; Hinz B
Curr Biol; 2011 Dec; 21(24):2046-54. PubMed ID: 22169532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
